🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03675P102
- IPO
- 12/13/2024 · $6.00/share
Business: Anteris Technologies Global Corp. is a structural heart company committed to designing, developing, and commercializing innovative medical devices. The Company's lead product, DurAVR®, is a transcatheter heart valve for treating aortic stenosis. It is the first transcatheter aortic valve replacement to use a single piece of bioengineered tissue. This biomimetic valve is uniquely shaped to mimic the performance of a healthy human aortic valve.
Company Contact
- CEO
- Wayne Paterson
- CFO
- Matthew McDonnell
- Investor Relations
- Malini Chatterjee, Blueprint Life Science Group · 917-330-4269 · investors@anteristech.com